Costs for orally administered cancer drugs skyrocket
Thursday, April 28, 2016 - 13:30
in Mathematics & Economics
New cancer drugs, taken in pill form, have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, calling into question the sustainability of a system that sets high prices at market entry in addition to rapidly increasing those prices over time.